Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide versus metformin in newly diagnosed overweight or obese type 2 diabetes
ChiCTR1900026485Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Jan 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liraglutide and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: Change in glycated hemoglobin. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
liraglutidemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1900026485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026485.